CLINICAL_TRIALS
trial_result
· 2014-01-27
Clinical Trial Update: Filibuvir In Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Subjects [Phase 2]
Summary
Pfizer's Phase 2 trial of filibuvir in treatment-naive hepatitis C virus genotype 1 subjects has completed and results were posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Hepatitis, Hepatitis C | Phase 2 | Status: COMPLETED | Results posted: 2014-01-27